Review Article
Mesenchymal Stem Cell Transplantation for Liver Cell Failure: A New Direction and Option
Table 3
The change of liver functions index after MSCT therapy.
| | Index | Follow-up of MSC group (month) | | Baseline (0) | 0.5 | 1 | 2 | 3 | 6 | 12 | 24 |
| | ALT (U/L) | 127.02 ± 96.71a | 60.11 ± 22.36b | 49.16 ± 11.12 | 36.98 ± 10.42 | 44.98 ± 17.97 | 49.4 ± 24.18 | NA | NA | | AST (U/L) | 232.4 ± 180.9 | 77.6 ± 10.3 | 71.6 ± 15.0 | NA | 85.0 ± 72.0 | 43.3 ± 19.6 | 35.0 ± 10.0 | 36.7 ± 9.6 | | TBIL (μmol/L) | 288.29 ± 140.54c | 173.40 ± 41.38 | 139.53 ± 30.91 | 78.57 ± 30.23d | 56.74 ± 18.40e | 180.19 ± 188.92 | NA | NA | | ALB (g/L) | 27.35 ± 3.85 | 29.03 ± 4.5 | 29.92 ± 4.06 | 27.08 ± 4.89 | 31.88 ± 3.79 | 30.57 ± 9.16 | NA | NA | | PT (s) | 23.35 ± 0.83 | 22.44 ± 1.83 | 20.08 ± 2.45 | NA | NA | NA | NA | NA |
|
|
Data are expressed as mean ± standard deviation. NA: not available; a, b, c, d, and e: . |
